Evidence map›Paper›PMID 31868683›Full record

ArticleJournal of Parkinson's disease2020

The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.

Ziv Gan-Or, Trisha Rao, Etienne Leveille, Clotilde Degroot, Sylvain Chouinard, Francesca Cicchetti, Alain Dagher, Samir Das, Alex Desautels, Janelle Drouin-Ouellet and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Association of Rare Variants in ARSA with Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.Journal of empirical research on human research ethics : JERHRE · 2025
    Trial
  5. Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  6. Article
  7. ThemedRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Altered network efficiency in isolated REM sleep behavior disorder: A multicentric study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Are rare heterozygousmedRxiv : the preprint server for health sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 1 country.

Ziv Gan-OrDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Trisha RaoClinical Research Unit, Montreal Neurological Institute, McGill University, Montréal, QC, Canada.
Etienne LeveilleMontreal Neurological Institute, McGill University, Montréal, QC, Canada.
Clotilde DegrootDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Sylvain ChouinardUnité des trouves du mouvement André Barbeau, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Francesca CicchettiCentre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.
Alain DagherMontreal Neurological Institute, McGill University, Montréal, QC, Canada.
Samir DasMcGill Centre for Integrative Neuroscience, Montreal Neurological Institute, Montreal, QC, Canada.
Alex DesautelsCentre d'Études Avancées en Médecine du Sommeil and Neurology Service, H-pital du Sacré-C-eur de Montréal, Montréal, QC, Canada.
Janelle Drouin-OuelletFaculty of Pharmacy, Université de Montréal, Montreal, Quebec, QC, Canada.
Thomas DurcanDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Jean-François GagnonCentre d'Études Avancées en Médecine du Sommeil and Neurology Service, H-pital du Sacré-C-eur de Montréal, Montréal, QC, Canada.
Angela GengeDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Jason KaramchandaniDepartment of Pathology, Montreal Neurological Institute, McGill University, Montréal, QC, Canada.
Anne-Louise LafontaineDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Sonia Lai Wing SunMontreal Neurological Institute, McGill University, Montréal, QC, Canada.
Mélanie LangloisDivision of Neurosciences, CHU de Québec, Université Laval, Québec City, QC, Canada.
Martin LevesqueDépartement de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada.
Calvin MelmedDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Michel PanissetUnité des trouves du mouvement André Barbeau, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Martin ParentDépartement de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada.
Jean-Baptiste PolineMontreal Neurological Institute, McGill University, Montréal, QC, Canada.
Ronald B PostumaDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Emmanuelle PourcherDivision of Neurosciences, CHU de Québec, Université Laval, Québec City, QC, Canada.
Guy A RouleauDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Madeleine SharpDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Oury MonchiDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Nicolas DupréDivision of Neurosciences, CHU de Québec, Université Laval, Québec City, QC, Canada.
Edward A FonDepartment of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute and Hospital · CAUniversité Laval · CACentre Hospitalier de l’Université de Montréal · CACanadian Sleep & Circadian Network · CACentre hospitalier universitaire de Québec · CAJewish General Hospital · CAUniversité de Montréal · CAUniversité du Québec à Montréal · CAUniversity of Calgary · CA

Funding

Resource DiscoveryP41EB019936 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI David Nelson Kennedy · 2016 to 2026
$15.2M
Exposing the Deep Content of the Publication: Knowledge Extraction for Neuroimaging in Child PsychiatryR01MH083320 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FRAZIER, JEAN A, KENNEDY, DAVID NELSON · 2009 to 2020
$6.3M
OPERATION, SUPPORT AND STRATEGIC ENHANCEMENT OF THE NEUROSCIENCE INFORMATION FRAMEWORKU24DA039832 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRETHE, JEFFREY S., MARTONE, MARYANN E · 2015 to 2016
$2.0M
CIHR FDN-154301NIBIB NIH HHS P41 EB019936NIDA NIH HHS U24 DA039832NIMH NIH HHS R01 MH083320
6 · The paper itself

Abstract

backgroundGenetic, biologic and clinical data suggest that Parkinson's disease (PD) is an umbrella for multiple disorders with clinical and pathological overlap, yet with different underlying mechanisms. To better understand these and to move towards neuroprotective treatment, we have established the Quebec Parkinson Network (QPN), an open-access patient registry, and data and bio-samples repository.

objectiveTo present the QPN and to perform preliminary analysis of the QPN data.

methodsA total of 1,070 consecutively recruited PD patients were included in the analysis. Demographic and clinical data were analyzed, including comparisons between males and females, PD patients with and without RBD, and stratified analyses comparing early and late-onset PD and different age groups.

resultsQPN patients exhibit a male:female ratio of 1.8:1, an average age-at-onset of 58.6 years, an age-at-diagnosis of 60.4 years, and average disease duration of 8.9 years. REM-sleep behavior disorder (RBD) was more common among men, and RBD was associated with other motor and non-motor symptoms including dyskinesia, fluctuations, postural hypotension and hallucinations. Older patients had significantly higher rates of constipation and cognitive impairment, and longer disease duration was associated with higher rates of dyskinesia, fluctuations, freezing of gait, falls, hallucinations and cognitive impairment. Since QPN's creation, over 60 studies and 30 publications have included patients and data from the QPN.

conclusionsThe QPN cohort displays typical PD demographics and clinical features. These data are open-access upon application (http://rpq-qpn.ca/en/), and will soon include genetic, imaging and bio-samples. We encourage clinicians and researchers to perform studies using these resources.

Indexed as

Biological Specimen BanksCognitive DysfunctionGait Disorders, NeurologicParkinson DiseaseRegistriesREM Sleep Behavior DisorderAgedAge of OnsetCohort StudiesFemaleHumansMaleMiddle AgedQuebecbiobankParkinson diseaseQuebec Parkinson Networkregistry

Identifiers

PMID31868683
PMCPMC7029361
OpenAlexW2994908519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.